Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to -$0.08.

  • Compass Therapeutics' EPS (Basic) changed 0.0% to -$0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.45, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of -$0.41 for FY2024, which is 2320.84% down from last year.
  • According to the latest figures from Q3 2025, Compass Therapeutics' EPS (Basic) is -$0.08, which was down 0.0% from -$0.14 recorded in Q2 2025.
  • In the past 5 years, Compass Therapeutics' EPS (Basic) ranged from a high of -$0.06 in Q1 2023 and a low of -$0.14 during Q2 2025
  • For the 3-year period, Compass Therapeutics' EPS (Basic) averaged around -$0.1, with its median value being -$0.09 (2023).
  • As far as peak fluctuations go, Compass Therapeutics' EPS (Basic) changed by 0.0% in 2024, and later plummeted by 5000.0% in 2025.
  • Over the past 3 years, Compass Therapeutics' EPS (Basic) (Quarter) stood at -$0.11 in 2023, then decreased by 14.23% to -$0.12 in 2024, then soared by 33.69% to -$0.08 in 2025.
  • Its last three reported values are -$0.08 in Q3 2025, -$0.14 for Q2 2025, and -$0.12 during Q1 2025.